Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Battelle, NxStage and Aethlon will collaborate on a mobile medical device to treat sepsis in soldiers, funded by a $23M contract with DARPA. The U.S. Defense Advanced Research Projects Agency (DARPA) handed a $23 million contract to 3 companies, Battelle, NxStage (NSDQ:NXTM) and Aethlon (OTC:AEMD), who will collaborate on a sepsis treatment device for the military. The project, which DARPA is calling the Dialysis-Like Therapeutics (DLT) program, will be funded in phases and the companies are tasked with building a portable sepsis treatment device.
Help employers find you! Check out all the jobs and post your resume.
Battelle, NxStage and Aethlon will collaborate on a mobile medical device to treat sepsis in soldiers, funded by a $23M contract with DARPA. The U.S. Defense Advanced Research Projects Agency (DARPA) handed a $23 million contract to 3 companies, Battelle, NxStage (NSDQ:NXTM) and Aethlon (OTC:AEMD), who will collaborate on a sepsis treatment device for the military. The project, which DARPA is calling the Dialysis-Like Therapeutics (DLT) program, will be funded in phases and the companies are tasked with building a portable sepsis treatment device.
Help employers find you! Check out all the jobs and post your resume.
